Form 4 for PFE Pfizer
Accepted 2022-03-01 00:00:00 ET · period of report 2022-02-26 · accession 0001225208-22-003724 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-01 | 2022-02-26 | PFE | SUSMAN SALLY | EVP | F - Tax | $49.51 | -48.4K | 154.1K | -24% | -$2.40M |
| D | 2022-03-01 | 2022-02-26 | PFE | SUSMAN SALLY | EVP | M - OptEx | $25.60 | +63.6K | 172.9K | +58% | +$1.63M |
| D | 2022-03-01 | 2022-02-26 | PFE | SUSMAN SALLY | EVP | M - OptEx | $0.00 | -63.6K | 0 | -100% | $0 |
| D | 2022-03-01 | 2022-02-28 | PFE | SUSMAN SALLY | EVP | A - Grant | $0.00 | +58.6K | 80.2K | +271% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-26 | F | D | 29,685 | $50.64 | 124,450 | D | — | — | (F4) The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). (F5) Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |
| 2 | Common | Common Stock | 2022-02-26 | M | A | 63,580 | $25.60 | 172,880 | D | — | — | (F1) The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
| 3 | Common | Common Stock | 2022-02-26 | F | D | 18,745 | $47.72 | 154,135 | D | — | — | (F2) The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. (F3) Price is the closing price of Pfizer common stock on February 25, 2022. |
| 4 | Derivative | Stock Appreciation Rights | 2022-02-26 | M | D | 63,580 | $0.00 | 0 | D | $25.60 · 2022-02-26 to 2022-02-26 | 63,580 Common Stock | |
| 5 | Derivative | Phantom Stock Units | 2022-02-28 | A | A | 58,623 | $0.00 | 80,225 | D | — · — to — | 58,623 Common Stock | (F7) The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon) which have been deferred into the Pfizer Inc. Deferred Compensation Plan. (F6) Each unit represents one phantom share of common stock. (F8) The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. |